BSE Live
Dec 30, 16:01Prev. Close
1717.50
Open Price
1717.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 30, 16:09Prev. Close
1717.20
Open Price
1723.10
Bid Price (Qty.)
1720.20 (96)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Sun Pharmaceutical Industries (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 7,882.47 | 2,823.77 | 2,329.75 | 2,463.10 | 1,985.78 | |
| Less: Excise/Sevice Tax/Other Levies | 151.55 | 99.46 | 86.35 | 64.93 | 52.66 | |
| Revenue From Operations [Net] | 7,730.92 | 2,724.31 | 2,243.40 | 2,398.17 | 1,933.12 | |
| Total Operating Revenues | 8,017.19 | 2,828.79 | 2,432.14 | 4,015.56 | 3,107.57 | |
| Other Income | 211.58 | 177.76 | 236.61 | 343.28 | 194.72 | |
| Total Revenue | 8,228.77 | 3,006.55 | 2,668.75 | 4,358.84 | 3,302.29 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 2,261.11 | 894.62 | 705.79 | 951.71 | 718.26 | |
| Purchase Of Stock-In Trade | 934.22 | 185.04 | 200.96 | 187.48 | 176.68 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 318.10 | -14.53 | -10.53 | -81.73 | 1.99 | |
| Employee Benefit Expenses | 1,486.68 | 279.63 | 234.87 | 316.56 | 261.09 | |
| Finance Costs | 551.25 | 18.38 | 0.44 | 0.43 | 0.59 | |
| Depreciation And Amortisation Expenses | 660.68 | 101.94 | 85.82 | 75.72 | 64.23 | |
| Other Expenses | 3,575.70 | 1,466.96 | 788.37 | 882.92 | 625.47 | |
| Total Expenses | 9,787.74 | 2,932.04 | 2,005.72 | 2,333.09 | 1,848.31 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -1,558.97 | 74.51 | 663.03 | 2,025.75 | 1,453.98 | |
| Exceptional Items | 0.00 | -2,875.60 | 0.00 | -299.92 | 0.00 | |
| Profit/Loss Before Tax | -1,558.97 | -2,801.09 | 663.03 | 1,725.83 | 1,453.98 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 108.00 | 0.00 | 114.98 | 22.94 | 57.00 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | -192.84 | 27.43 | 31.50 | 5.40 | 13.18 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | -84.84 | 27.43 | 146.48 | 28.34 | 70.18 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -1,474.13 | -2,828.52 | 516.55 | 1,697.49 | 1,383.80 | |
| Profit/Loss From Continuing Operations | -1,474.13 | -2,828.52 | 516.55 | 1,697.49 | 1,383.80 | |
| Profit/Loss For The Period | -1,474.13 | -2,828.52 | 516.55 | 1,697.49 | 1,383.80 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | -6.00 | -13.70 | 5.00 | 16.40 | 13.40 | |
| Diluted EPS (Rs.) | -6.00 | -13.70 | 5.00 | 16.40 | 13.40 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 1,046.66 | 419.50 | 384.45 | 380.02 | 297.65 | |
| Indigenous Raw Materials | 1,214.45 | 475.12 | 321.34 | 571.69 | 420.61 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 77.99 | 52.13 | 52.60 | 35.94 | 27.69 | |
| Indigenous Stores And Spares | 267.50 | 132.80 | 118.52 | 82.66 | 70.64 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 721.95 | 310.67 | 517.79 | 440.12 | 362.45 | |
| Tax On Dividend | 146.97 | 52.80 | 88.00 | 71.40 | 58.80 | |
| Equity Dividend Rate (%) | 300.00 | 150.00 | 500.00 | 425.00 | 350.00 |
20.11.2025
12.11.2025
11.11.2025
Buy Sun Pharmaceutical Industries; target of Rs 1875 Prabhudas Lilladher
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
01.08.2025
Sun Pharma Consolidated June 2025 Net Sales at Rs 13,851.40 crore, up 9.47% Y-o-Y
31.07.2025
Sun Pharma Standalone June 2025 Net Sales at Rs 5,601.96 crore, up 24.54% Y-o-Y
22.05.2025
Sun Pharma Q4 net profit declines 19% to Rs 2,154 crore, firm declares Rs 5.50 dividend